The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030:By RootsAnalysis:

Your avatar
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers 
Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”

The report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of companies offering patient recruitment and retention services.
An analysis of the most active regions (in terms of patient recruitment activity) engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.
An insightful 2X2 representation of the results of a competitiveness analysis of various service providers highlighting capable players in this domain, based on their respective capabilities.
Comprehensive profiles of patient recruitment and retention service providers (shortlisted on the basis of the number of services).
An analysis of the partnerships that have been established in this domain, in the recent past
A review of emerging trends in the industry to overcome the challenges associated with patient recruitment and retention
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Therapeutic Area
Infectious Diseases
Cardiovascular Diseases
CNS Disorders
Respiratory Disorders
Metabolic Disorders
Steps in Patient Recruitment Process
Phase of Development
Phase I
Phase II
Phase III
Phase IV
Key Geographical Region
North America
Rest of the world
Transcripts of interviews held with the following senior level representatives of stakeholder companies
  • Simon Klaasen, Co-founder and Managing Director, Link2Trials
  • Hagit Nof, Chief Operation Officer and Business Development Officer, nRollmed
  • Paul Ivsin, Managing Director, Seeker Health

Key companies covered in the report
BBK Worldwide
Bright Pharmaceuticals Services
Ignite Data
Integrated Clinical Trial Services
Pacific Groove
Polaris BioPharma Consulting
Topstone Research
Tudor Reilly Health
WCCT Global
For more information please click on the following link:
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415

Keep discovering on Mamby:

If you liked this post, you may also be interested in...
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments